IP Library Granted Patent US 10,794,817
Granted Patent B1
US 10,794,817 · App. 16/924,492 · Granted Oct 6, 2020

Cell capture system and method of use

Inventor: Kalyan Handique (Ann Arbor, MI)
Assignee: Bio-Rad Laboratories, Inc.
G01N15/1484B01L3/021B01L3/502715B01L3/502746B01L3/502761C12M47/04G01N1/20G01N1/28G01N1/40G01N1/405B01L2200/0652B01L2200/0668B01L2300/0636B01L2300/0654B01L2300/0672B01L2300/0816B01L2300/0819B01L2300/0848B01L2300/0877B01L2300/168B01L2400/086G01N1/4077G01N2015/0065G01N2015/1006G01N2015/149G01N2035/00158G06K9/00127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,794,817
App. No.
16/924,492
Granted
Oct 6, 2020
Kind
B1
Abstract

A cell capture system including an array, an inlet manifold, and an outlet manifold. The array includes a plurality of parallel pores, each pore including a chamber and a pore channel, an inlet channel fluidly connected to the chambers of the pores; an outlet channel fluidly connected to the pore channels of the pores. The inlet manifold is fluidly connected to the inlet channel, and the outlet channel is fluidly connected to the outlet channel. A cell removal tool is also disclosed, wherein the cell removal tool is configured to remove a captured cell from a pore chamber.

Claims (25)

1. A method comprising:

providing a substrate comprising an inlet opening, one or more outlet openings at a downstream end, and an array of chambers in fluid communication with the inlet opening and the one or more outlet openings, wherein flow from the inlet opening is configured to reach at least one of the one or more outlet openings only upon passing the array of chambers;

receiving a set of functionalized beads into the substrate, thereby spatially distributing the set of functionalized beads across the array of chambers in single-particle format;

co-capturing target components of a sample at the set of chambers, with the set of functionalized beads;

at the substrate, enabling performance of a set of processes with the target components of the sample and the set of functionalized beads; and

through the substrate, transmitting detectable features derived from target components of the sample distributed across the set of chambers.

2. The method of claim 1 , wherein the set of functionalized beads comprises affinity-coated microspheres.

3. The method of claim 1 , wherein the target components of the sample comprise a set of target cells.

4. The method of claim 3 , wherein enabling performance of the the set of processes comprises receiving a lysis reagent into the substrate, thereby allowing lysis of the set of target cells for release of cellular material and binding of cellular material with the set of functionalized beads.

5. The method of claim 1 , wherein the target components of the sample comprise biological markers of the sample.

6. The method of claim 1 , wherein the target components of the sample comprise antibody-associated contents of the sample.

7. The method of claim 1 , wherein co-capturing target components of the sample at the set of chambers, with the set of functionalized beads, comprises capturing a set of molecules released from lysed cells, within the set of chambers, at the set of functionalized beads proximal to the set of molecules.

8. The method of claim 1 , wherein the set of processes comprises at least one of: a molecular reaction, an amplification process, single cell proteomic analysis, nucleic acid analysis, and genomic sequencing.

9. The method of claim 1 , wherein transmitting detectable features derived from target components of the sample comprises transmitting fluorescence-associated features through the substrate.

10. The method of claim 9 , further comprising receiving excitation light at the array of chambers, and transmitting emitted light from contents of the array of chambers.

11. The method of claim 1 , wherein the set of processes comprises a wash process involving receiving a wash solution into the substrate, and washing contents of the array of chambers with the wash solution.

12. The method of claim 1 , wherein the set of processes comprises an isolation process involving isolating contents of the array of chambers with an isolation material.

13. The method of claim 12 , wherein the isolation material comprises at least one of an oil and air.

14. The method of claim 1 , wherein transmitting detectable features derived from target components of the sample comprises transmitting features indicative of protein presence.

15. The method of claim 1 , wherein co-capturing target components of the sample comprises receiving a cell suspension into the inlet opening of the substrate.

16. The method of claim 1 , wherein each of the array of chambers is displaced from adjacent chambers by one or more barriers configured to fluidly isolate contents of each chamber.

17. The method of claim 1 , wherein the set of functionalized beads comprises a set of magnetic beads.

18. The method of claim 1 , wherein the set of processes comprises a retention process involving positioning the substrate in proximity to a magnetic field provided by a magnet, and retaining target material in position within the array of chambers of the substrate, by way of the magnetic field.

19. The method of claim 1 , wherein the array of chambers comprises a two-dimensional array of chambers.

20. The method of claim 1 , wherein each of the array of chambers comprises a characteristic dimension less than 200 micrometers.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: CELSEE, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 054269/0742 →
CHANGE OF NAME Recorded Sep 24, 2020
From: CELSEE DIAGNOSTICS, INC.
To: CELSEE, INC.
Reel/Frame 053881/0555 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2020
From: HANDIQUE, KALYAN
To: DENOVO SCIENCES, INC.
Reel/Frame 053372/0830 →
CHANGE OF NAME Recorded Jul 31, 2020
From: DENOVO SCIENCES, INC.
To: CELSEE DIAGNOSTICS, INC.
Reel/Frame 053377/0100 →
Continuity (13)
Continuation 16835603 · Mar 31, 2020
Continuation 16679639 · Nov 11, 2019
Continuation 16599704 · Oct 11, 2019
Continuation 16536155 · Aug 8, 2019
Continuation 16513580 · Jul 16, 2019
Continuation 16443140 · Jun 17, 2019
Continuation 16419254 · May 22, 2019
Continuation 16048104 · Jul 27, 2018
Continuation 15657553 · Jul 24, 2017
Continuation 15333420 · Oct 25, 2016
Continuation 14607918 · Jan 28, 2015
Continuation 13557510 · Jul 25, 2012
Provisional Application 61513785 · Aug 1, 2011